Results 111 to 120 of about 81,441 (250)

Apple Pomace Pectin for Gastroprotective Nutraceutical Delivery: Structure–Function Relationships and Nano/Microencapsulation Strategies for Gastric Ulcer Management

open access: yesFood Frontiers, Volume 7, Issue 4, July 2026.
Apple pomace pectin is explored as a sustainable and multifunctional biomaterial for gastric ulcer management. Its unique structural features confer mucoadhesive, anti‐inflammatory, antioxidant, and anti‐Helicobacter pylori activities while enabling nano/microencapsulation of therapeutic agents.
Akash Dhiman   +6 more
wiley   +1 more source

Primary Percutaneous Coronary Intervention

open access: yesJournal of the American College of Cardiology, 2013
Grines, Cindy L., Schreiber, Theodore
openaire   +1 more source

Early Versus Late Wake‐Up Call After Out‐Of‐Hospital Cardiac Arrest: Protocol for a Multicenter Randomized Comparison Within the Danish Out‐of‐Hospital Cardiac Arrest (DANOHCA) Trial

open access: yesActa Anaesthesiologica Scandinavica, Volume 70, Issue 6, July 2026.
ABSTRACT Background Survivors of out‐of‐hospital cardiac arrest (OHCA) who remain comatose after return of spontaneous circulation are routinely sedated and mechanically ventilated during early post‐resuscitation care. Although prolonged sedation has traditionally been considered necessary, contemporary normothermia‐based temperature control allows ...
Anders Morten Grejs   +12 more
wiley   +1 more source

Effects of Sedation, TEmperature and Pressure After Cardiac Arrest and REsuscitation on Major Adverse Kidney Events (STEPCARE‐MAKE): A Protocol for a Pre‐Planned Sub‐Study of a Randomized Clinical Trial

open access: yesActa Anaesthesiologica Scandinavica, Volume 70, Issue 6, July 2026.
ABSTRACT Background Acute kidney injury (AKI) is a common and serious complication after cardiac arrest, affecting more than 30% of initially successfully resuscitated patients, with around 10% receiving Kidney Replacement Therapy (KRT). Currently, treatment options to prevent renal complications are limited.
Keski‐Keturi M   +76 more
wiley   +1 more source

Primary Percutaneous Coronary Intervention in the Very Elderly: A Realistic Intervention?

open access: yesJournal of the Royal College of Physicians of Edinburgh, 2021
Sajeel, Ahmed   +2 more
openaire   +2 more sources

Longer Baseline Left Ventricular Activation Time Is Associated With Lower Mortality and Lower Risk of Heart Failure Hospitalization in Cardiac Resynchronization Therapy Recipients

open access: yesAnnals of Noninvasive Electrocardiology, Volume 31, Issue 4, July 2026.
In patients undergoing CRT implantation, a longer pre‐implant LVAT was linked to better clinical outcome (lower risk of heart failure hospitalization and all‐cause mortality), suggesting that LVAT may help refine risk stratification after CRT. ABSTRACT Introduction Many patients do not benefit from cardiac resynchronization therapy (CRT) with current ...
Sofia Marinko   +2 more
wiley   +1 more source

GLP‐1 Receptor Agonist Therapy and Cardiorenal Outcomes in Type 1 Diabetes: A Propensity‐Matched Real‐World Analysis

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 7, Page 6347-6357, July 2026.
ABSTRACT Aims Evidence on cardiovascular/renal outcomes associated with GLP‐1‐based therapies in type 1 diabetes (T1D) is limited. We examined the effects of GLP‐1‐based therapy on major clinical outcomes and safety, including diabetic ketoacidosis (DKA) and hypoglycemia risk, in adults with T1D in a large real‐world cohort.
Anastasios Tentolouris   +7 more
wiley   +1 more source

Coronary No-Reflow after Primary Percutaneous Coronary Intervention

open access: yesOpen Access Journal of Cardiology
Coronary no-reflow is a significant complication following primary percutaneous coronary intervention (PCI) in patients with acute myocardial infarction. This phenomenon involves inadequate myocardial perfusion despite successful vessel recanalization, attributed to factors such as microvascular injury, inflammation, thrombus embolization, and ...
openaire   +1 more source

Home - About - Disclaimer - Privacy